Icahn School of Medicine at Mount Sinai
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
By
Icahn School of Medicine at Mount Sinai
FEATURING
Kuo-Kai Chin
By
Icahn School of Medicine at Mount Sinai
FEATURING
Kuo-Kai Chin
Login to view comments.
Click here to Login
Myeloid Malignancy Workshop